Status:
RECRUITING
A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection
Lead Sponsor:
Latin American Cooperative Oncology Group
Conditions:
Anal Squamous Cell Carcinoma
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
Due to the scarcity of data on prognostic and predictive influence on CCA, epidemiological studies evaluating these factors need to be developed in patients with CCA. Therefore, the investigators want...
Eligibility Criteria
Inclusion
- Patients 18 years of age or older
- Confirmed histological diagnosis of anal canal squamous cell carcinoma. Basaloid subtype is accepted
- Have underundered serological test for HIV infection
- Any clinical stage
Exclusion
- Lack of data on treatments and clinical outcomes
Key Trial Info
Start Date :
June 9 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 24 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05328765
Start Date
June 9 2023
End Date
April 24 2025
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
A.C. Camargo Cancer Center
São Paulo, Brazil, 01509-001